🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

EJVES isabelle vanherzeele Hany Zayed @K_Stavroulakis This was yet another collaboration across Europe 🌍 delivered by RCPAD - see details about our group on rcpad.org & feel free to send suggestions for #PAD projects if you wish to expand your research internationally 👇🏻

It was a great privilege to discuss the topic of CLTI with like-minded colleagues who share the same passion for limb salvage.

There are just over 2 weeks to go until STARS 2024! We are pleased to once again have live case transmission sessions on the programme supported by Proximie There is still time to register to join us in London on the 5-6 July. starsymposium.co.uk

10 years of the STARS #PAD conference in London today. Hear about the latest in vascular diseases including our several RCTs looking for new sites & more recruits!

Really honored to have been part of the 10th Anniversary of the STARS conference in London. Great extreme BTK revascularization session. Many thanks Hany Zayed for your kind invitation! 🤗

We are finishing up day one with speakers going through their ‘nightmare cases’ and how they overcome various challenges.

THANK YOU to each and every one who has been a part of this wonderful journey🙏🙏

Hany Zayed Congratulations Hany and team for their 10 yr anniversary of their highly commendable conference. Wish you all the more successful years ahead

Food for thought: in the last 15 years (or so), 5 or so NHS hospitals have recruited almost all UK participants in the completed/ongoing large National Institute for Health and Care Research British Heart Foundation vascular trials, 1/2

Don't miss this latest #EJVESOA "COST anaLYsis of Target Lesion Revascularization (TLR) in patients with femoropopliteal in-stent-restenosis or occlusion: the COSTLY-TLR study" Athanasios Saratzis isabelle vanherzeele Hany Zayed Mario D'Oria, MD @K_Stavroulakis doi.org/10.1016/j.ejvs…

Athanasios Saratzis isabelle vanherzeele Hany Zayed Mario D'Oria, MD @K_Stavroulakis We all want to avoid TLR, but at what cost, and what factors drive it? Maybe more expensive primary technology is appropriate, if TLR can be avoided? Including 482 TLR procedures, from 13 hospitals and 6 countries! Read the full article to find out more! doi.org/10.1016/j.ejvs…

Latest ESVS EJVES vessel preparation work from our international PAD team Hany Zayed. Take home ✉️: This is a clinical area in DESPERATE need for high quality randomised research in order to inform & standardise practice. See👇🏻 doi.org/10.1016/j.ejvs…

A shift away from primary lower-limb amputation in PAD leads to substantial savings for the NHS without major cost increases later in the care pathway. Revascularise legs please! 🙏🏻 academic.oup.com/bjsopen/articl…

This work builds on our prior recent research, also showing that a primary amputation in CLTI leads to more postoperative appointments in community & secondary healthcare BJS Open - funded by Abbott Abbott Cardiovascular

Economic impact of limb-salvage strategies in chronic limb-threatening ischaemia: modelling and budget impact study based on national registry data ➡️doi.org/10.1093/bjsope… Missed opportunities to reduce numbers of primary major lower-limb amputation and increase limb-salvage

📣 Calling all ESVS members 🫵The ESVS EDI Task Force needs your help! The group has been tasked with assessing the current situation and producing an action plan on how to improve it. One of the first tasks the group has undertaken is is drafting some recommendations on how to

PAD is the commonest cause of leg amputation. With Abbott support we showed that #CLTI leg revascularisation is more cost effective vs. amputation. This fed into the #AmpuNation campaign raising awareness on PAD treatments. On Channel 4 News today 👇🏻 youtu.be/yOJgntA0ytw?si…

If you watch anything today LET IT BE THIS. If you share anything today, LET IT BE THIS. May we have more and more EU leaders like this, stepping up and speaking truth to power. Laughing at the deaths of innocent civilians. Disgrace doesn’t even come close. The

It was a pleasure having such an enthusiastic young doctor around, even for a short time. All the best in the next chapter of your career 🙏

'RAndomised controlled trial assessing the clinical and cost-effectiveness of Endovascular vs. Open revascularisation for common Femoral artery steno-occlusive disease'. The RAF Trial. COMING SOON 🇬🇧 ...brace yourselves 😉